Visweswaran Ravikumar

5PUBLICATIONS
50CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Transplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 24, 2026
Microenvironment-derived acetylated amino acids promote glioblastoma treatment resistance.

|Nov 24, 2025
Spatial transcriptomics of glioblastoma defines biologically and clinically significant reprogramming patterns across unique spatial microenvironments.

Visweswaran Ravikumar, Avery Maddox, Reva Kulkarni

|Nov 12, 2021
Quantifying T2-FLAIR Mismatch Using Geographically Weighted Regression and Predicting Molecular Status in Lower-Grade Gliomas.

S Mohammed, V Ravikumar, E Warner

|Oct 13, 2021
Epigenetically defined therapeutic targeting in H3.3G34R/V high-grade gliomas.

Stefan R Sweha, Chan Chung, Siva Kumar Natarajan

|Mar 18, 2021
RNA-seq of human T cells after hematopoietic stem cell transplantation identifies Linc00402 as a regulator of T cell alloimmunity.

Daniel Peltier, Molly Radosevich, Visweswaran Ravikumar

Pageof 1

Frequent Collaborators

3 joint publications

Arvind Rao

2 joint publications

Andrew Scott

2 joint publications

Arul M Chinnaiyan

1 joint publications

S Mohammed